EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
153 hedge funds and large institutions have $337M invested in Eagle Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 47 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
-10
Holders Change %
-6.13%
% of All Funds
2.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
63
Reduced
47
Closed
32
Calls
$3.6M
Puts
–
Net Calls
+$3.6M
Net Calls Change
+$3.6M
